Build What Comes Next

Invest in better answers for tickborne diseases. Your support fuels science, trials and infrastructure.

Opportunity

Tickborne illness is a growing global issue. There is tremendous opportunity for impact when science meets unmet need.

Millions of cases reported annually, with significant underreporting. Demand for diagnostics and treatments expanding.

Few companies investing in tick-borne disease solutions. Our focused expertise creates competitive advantage.

Drive financial returns while improving lives and reducing long-term healthcare burdens.

We follow a disciplined plan from early research to market with clear objectives.

Establish core team and secure initial funding

Advance lead candidates and expand R&D

Complete phase II trials and scale manufacturing

Launch products and expand geographically

Capital allocated responsibly across research, trials, operations and engagement.

Refine assays, produce reagents and support cross-disciplinary teams.

Run ethical, diverse studies meeting regulatory standards.

Build labs, data platforms and distribution networks.

Educate patients, clinicians and advocates.

Ready to explore partnership opportunities? Contact us directly.